跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 313 条关于
“REGENCY”
全部
313
临床试验
193
药物
17
机构
28
资讯
75
去年
Gazyva Shows Significant Improvement in Lupus Nephritis Treatment: Phase III REGENCY Trial Results
去年
Genentech's Gazyva Shows Positive Phase III Results in Lupus Nephritis Treatment
去年
Obinutuzumab Shows Positive Results in Phase 3 Trial for Lupus Nephritis
去年
Genentech's Gazyva Demonstrates Efficacy in Phase 3 Lupus Nephritis Trial
11个月前
Roche's Obinutuzumab Awaits FDA Decision as Lupus Market Analysis Reveals Launch Success Factors
10个月前
Genentech's Gazyva Shows Significant Efficacy in Phase III Trial for Pediatric Idiopathic Nephrotic Syndrome
去年
Novel Therapies Transform Rheumatology Landscape in Early 2025
去年
OCT West Coast 2025 Conference to Focus on Trial Efficiency, AI Integration, and Patient-Centricity
去年
Roche Reports Strong Q3 Growth Driven by Key Pharmaceuticals and Diagnostics
去年
Regenity Biosciences' RejuvaKnee Implant Receives FDA Clearance for Meniscal Repair
第 1 页,共 8 页
上一页
下一页